MedTrace Logo

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

NCT04842266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-16

No results posted yet for this study

Summary

The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility fractures. Results from this study will be used to confirm preliminary clinically and possibly statistically significant reductions in pain and improvements in function among these patients.

Conditions

  • Cancer Metastatic
  • Trauma
  • Pathologic Fracture

Interventions

DEVICE

IlluminOss pelvic implant for oncologic indication

Impending or actual non-displaced or minimally displaced pathologic fractures of the pelvis

DEVICE

IlluminOss pelvic implant for geriatric trauma indication

Pelvic fragility fracture in a geriatric patients (age 65 or older)

Sponsors & Collaborators

  • IlluminOss Medical, Inc.

    collaborator INDUSTRY

  • University of Miami

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-18
Primary Completion
2027-11-30
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04842266 on ClinicalTrials.gov